GRP/BN promotes breast cancer growth and progression [4, 5]; the occurrence of these high-affinity receptors in breast cancer has instigated the scientists to develop newer BN-based diagnostic agents [6, 7]. This evidence concerns the gene GRP and breast carcinoma.